Pacific Biosciences of California, Inc. (PACB)
USD 1.13
(1.8%)
USD 1.13
(1.8%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 52.78 Million USD | -17.72% |
| 2022 | 49.03 Million USD | -16.69% |
| 2021 | 58.86 Million USD | 80.74% |
| 2020 | 32.56 Million USD | -5.81% |
| 2019 | 34.57 Million USD | 37.77% |
| 2018 | 25.09 Million USD | -27.59% |
| 2017 | 34.65 Million USD | -21.51% |
| 2016 | 44.16 Million USD | -17.38% |
| 2015 | 53.45 Million USD | 128.4% |
| 2014 | 23.4 Million USD | 264.57% |
| 2013 | 6.41 Million USD | 582.87% |
| 2012 | 940 Thousand USD | -92.79% |
| 2011 | 13.03 Million USD | 678.61% |
| 2010 | 1.67 Million USD | 1140.0% |
| 2009 | 135 Thousand USD | -85.02% |
| 2008 | 901 Thousand USD | -58.34% |
| 2007 | 2.16 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.42 Million USD | -59.75% |
| 2024 Q2 | 3.68 Million USD | 34.07% |
| 2023 Q2 | 15.54 Million USD | 59.27% |
| 2023 Q1 | 9.76 Million USD | 89.9% |
| 2023 Q4 | 11 Million USD | -38.53% |
| 2023 Q3 | 17.9 Million USD | 15.16% |
| 2023 FY | 40.34 Million USD | -17.72% |
| 2022 Q3 | 13.54 Million USD | -16.34% |
| 2022 Q2 | 16.19 Million USD | 14.4% |
| 2022 Q4 | 5.14 Million USD | -62.06% |
| 2022 FY | 49.03 Million USD | -16.69% |
| 2022 Q1 | 14.15 Million USD | -15.57% |
| 2021 FY | 58.86 Million USD | 80.74% |
| 2021 Q1 | 12.97 Million USD | 13.82% |
| 2021 Q2 | 13.75 Million USD | 5.98% |
| 2021 Q3 | 15.36 Million USD | 11.71% |
| 2021 Q4 | 16.76 Million USD | 9.13% |
| 2020 Q3 | 7.06 Million USD | 6.82% |
| 2020 Q2 | 6.61 Million USD | -11.69% |
| 2020 Q1 | 7.48 Million USD | -42.1% |
| 2020 FY | 32.56 Million USD | -5.81% |
| 2020 Q4 | 11.4 Million USD | 61.4% |
| 2019 FY | 34.57 Million USD | 37.77% |
| 2019 Q1 | 5.11 Million USD | -10.95% |
| 2019 Q2 | 9.61 Million USD | 87.86% |
| 2019 Q3 | 6.91 Million USD | -28.08% |
| 2019 Q4 | 12.93 Million USD | 87.04% |
| 2018 Q3 | 3.19 Million USD | -63.98% |
| 2018 Q1 | 7.29 Million USD | -23.15% |
| 2018 FY | 25.09 Million USD | -27.59% |
| 2018 Q4 | 5.74 Million USD | 80.01% |
| 2018 Q2 | 8.86 Million USD | 21.46% |
| 2017 Q1 | 8.93 Million USD | -21.43% |
| 2017 FY | 34.65 Million USD | -21.51% |
| 2017 Q4 | 9.49 Million USD | 15.4% |
| 2017 Q3 | 8.22 Million USD | 2.82% |
| 2017 Q2 | 8 Million USD | -10.47% |
| 2016 Q2 | 10.64 Million USD | 11.99% |
| 2016 Q3 | 12.63 Million USD | 18.73% |
| 2016 Q4 | 11.37 Million USD | -10.0% |
| 2016 FY | 44.16 Million USD | -17.38% |
| 2016 Q1 | 9.5 Million USD | -64.09% |
| 2015 Q4 | 26.46 Million USD | 304.0% |
| 2015 Q1 | 5.92 Million USD | 33.55% |
| 2015 Q2 | 14.5 Million USD | 144.74% |
| 2015 Q3 | 6.55 Million USD | -54.84% |
| 2015 FY | 53.45 Million USD | 128.4% |
| 2014 Q3 | 13.16 Million USD | 321.05% |
| 2014 Q1 | 2.67 Million USD | -16.09% |
| 2014 FY | 23.4 Million USD | 264.57% |
| 2014 Q4 | 4.43 Million USD | -66.28% |
| 2014 Q2 | 3.12 Million USD | 16.82% |
| 2013 Q4 | 3.18 Million USD | 156.97% |
| 2013 Q3 | 1.24 Million USD | 17.19% |
| 2013 Q2 | 1.05 Million USD | 13.87% |
| 2013 Q1 | 930 Thousand USD | 48.33% |
| 2013 FY | 6.41 Million USD | 582.87% |
| 2012 Q1 | -152 Thousand USD | -109.89% |
| 2012 Q2 | 275 Thousand USD | 280.92% |
| 2012 Q4 | 627 Thousand USD | 230.0% |
| 2012 Q3 | 190 Thousand USD | -30.91% |
| 2012 FY | 940 Thousand USD | -92.79% |
| 2011 Q2 | 7.89 Million USD | 2825.56% |
| 2011 Q1 | 270 Thousand USD | -3.57% |
| 2011 FY | 13.03 Million USD | 678.61% |
| 2011 Q4 | 1.53 Million USD | -53.82% |
| 2011 Q3 | 3.32 Million USD | -57.87% |
| 2010 Q3 | 220 Thousand USD | -65.02% |
| 2010 Q4 | 280 Thousand USD | 27.27% |
| 2010 Q1 | 545 Thousand USD | 303.7% |
| 2010 FY | 1.67 Million USD | 1140.0% |
| 2010 Q2 | 629 Thousand USD | 15.41% |
| 2009 Q4 | 135 Thousand USD | 0.0% |
| 2009 FY | 135 Thousand USD | -85.02% |
| 2009 Q3 | - USD | 0.0% |
| 2008 FY | 901 Thousand USD | -58.34% |
| 2007 FY | 2.16 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| electroCore, Inc. | 13.22 Million USD | -299.062% |
| NeuroPace, Inc. | 48.12 Million USD | -9.68% |
| Sight Sciences, Inc. | 69.17 Million USD | 23.701% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -231.824% |
| SI-BONE, Inc. | 109.42 Million USD | 51.764% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 48.801% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -1969.804% |
| Cerus Corporation | 86.4 Million USD | 38.912% |
| Axonics, Inc. | 274.55 Million USD | 80.776% |
| 908 Devices Inc. | 25.32 Million USD | -108.435% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 65.262% |
| TELA Bio, Inc. | 40.11 Million USD | -31.582% |
| Venus Concept Inc. | 52.16 Million USD | -1.175% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -18290.244% |
| RxSight, Inc. | 53.76 Million USD | 1.832% |
| LENSAR, Inc. | 21.1 Million USD | -150.059% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 1062.261% |
| LivaNova PLC | 771.25 Million USD | 93.157% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 13100.0% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 972.397% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 82.985% |
| Apyx Medical Corporation | 14.12 Million USD | -273.743% |
| Cutera, Inc. | 41.49 Million USD | -27.199% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -185.9% |
| BioSig Technologies, Inc. | 18 Thousand USD | -293122.222% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 94.059% |
| Bioventus Inc. | 328.19 Million USD | 83.918% |
| Envoy Medical, Inc. | -473 Thousand USD | 11258.562% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -86424.59% |
| Outset Medical, Inc. | 29 Million USD | -82.0% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -61950.317% |
| IRIDEX Corporation | 21.8 Million USD | -142.032% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 25.713% |
| IRadimed Corporation | 50.15 Million USD | -5.227% |
| PAVmed Inc | -3.96 Million USD | 1430.141% |
| INVO Bioscience, Inc. | 1.08 Million USD | -4759.419% |
| Movano Inc. | -158 Thousand USD | 33505.063% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 51.766% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -11461.453% |
| Spectral AI, Inc. | 7.88 Million USD | -569.797% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 53.202% |
| Varex Imaging Corporation | 256.9 Million USD | 79.455% |
| Quipt Home Medical Corp. | 163.84 Million USD | 67.787% |
| IceCure Medical Ltd | 1.3 Million USD | -3960.0% |
| Pulmonx Corporation | 50.75 Million USD | -3.996% |
| Modular Medical, Inc. | -768 Thousand USD | 6972.396% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -851.334% |
| Insulet Corporation | 1.15 Billion USD | 95.45% |
| Semler Scientific, Inc. | 61.2 Million USD | 13.758% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -287.689% |
| Orthofix Medical Inc. | 486.27 Million USD | 89.146% |
| InMode Ltd. | 411.34 Million USD | 87.169% |
| Bruker Corporation | 1.51 Billion USD | 96.52% |
| Surmodics, Inc. | 93.05 Million USD | 43.279% |
| Cytosorbents Corporation | 22.39 Million USD | -135.709% |
| iCAD, Inc. | 14.53 Million USD | -263.099% |
| DexCom, Inc. | 2.28 Billion USD | 97.694% |
| Align Technology, Inc. | 2.71 Billion USD | 98.059% |
| ZimVie Inc. | 290.38 Million USD | 81.824% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -61950.317% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| BrainsWay Ltd. | 23.09 Million USD | -128.574% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 85.646% |
| Profound Medical Corp. | 4.51 Million USD | -1069.246% |
| enVVeno Medical Corporation | -546 Thousand USD | 9766.667% |
| Nuwellis, Inc. | 4.98 Million USD | -959.201% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 900.667% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 14799.616% |
| Inogen, Inc. | 126.69 Million USD | 58.342% |
| MaxCyte, Inc. | 36.54 Million USD | -44.421% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 84.093% |
| OrthoPediatrics Corp. | 111.25 Million USD | 52.559% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| InspireMD, Inc. | 1.8 Million USD | -2820.863% |
| PAVmed Inc. | -3.96 Million USD | 1430.141% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 111600.761% |
| BIOLASE, Inc. | 16.72 Million USD | -215.594% |
| Beyond Air, Inc. | -1.3 Million USD | 4138.256% |
| FONAR Corporation | 45.14 Million USD | -16.925% |
| AxoGen, Inc. | 127.87 Million USD | 58.725% |
| Vivani Medical, Inc. | -357 Thousand USD | 14884.314% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 72.952% |
| Inari Medical, Inc. | 434.56 Million USD | 87.854% |
| UFP Technologies, Inc. | 112.22 Million USD | 52.969% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -421499.169% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -1909.068% |
| Tenon Medical, Inc. | 1.24 Million USD | -4153.022% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 65260.494% |
| CVRx, Inc. | 33.03 Million USD | -59.751% |
| AdaptHealth Corp. | 479.56 Million USD | 88.994% |
| Sintx Technologies, Inc. | 1.84 Million USD | -2763.809% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -538.133% |
| NanoVibronix, Inc. | 1.53 Million USD | -3333.962% |
| Quanterix Corporation | 70.64 Million USD | 25.289% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 13100.0% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -275.391% |
| TransMedics Group, Inc. | 154.09 Million USD | 65.748% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -1085.268% |
| NeuroMetrix, Inc. | 3.94 Million USD | -1237.078% |
| Hyperfine, Inc. | 4.75 Million USD | -1009.523% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 50.662% |
| Biomerica, Inc. | 611 Thousand USD | -8538.298% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -26.609% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 6858.392% |
| Silk Road Medical, Inc | 127.08 Million USD | 58.469% |